期刊文献+

^(31)P-MRS检测标记基因表达肝直接基因转导初步研究

Preliminary study on monitoring marked gene expression of liver direct gene transduction by ^(31)P-MRS
下载PDF
导出
摘要 目的:探讨31P-MRS技术在兔VX2肝移植瘤模型经AdCMVIL12-IRES-CKb腺病毒基因转导后通过标记基因间接表达的可行性。方法:健康新西兰大白兔20只,采用开腹包埋法建立兔VX2肝肿瘤模型,将种植成功的18只实验兔随机分成两组,于3周左右行31P-MRS扫描后采用开腹法分别将等量AdCMVIL12-IRES-CKb腺病毒和生理盐水注射到两组瘤兔肿瘤及周围组织中,肌酸水溶液饲养5天后再次行31P-MRS扫描。同时通过免疫组化、琼脂糖凝胶蛋白印迹法(Western Blot)对IL-12和CK进行检测。结果:经AdCMVIL12-IRES-CKb腺病毒治疗后的兔肝VX2肿瘤组织PCr峰较对照组明显升高,分别为(0.84±0.41)、(0.23±0.29)mmol/L,两组治疗前后PCr比较,P值小于0.05,差异有统计学意义;免疫组化在治疗组肝脏局部组织中检测到IL-12的表达,对照组未见表达;Western Blot法检测到治疗组CKB的表达,但对照组未见表达。结论:通过31P-MRS成像检测病毒直接基因转导后体内肝脏的基因表达是可行的。 Objective:To explore the feasibility of ^31P-MRS technology expressing indirectly by marker gene in the rabbit VX2 liver transplantation tumor models after AdCMVIL12-IRES-CKb adenoviral gene transducting.Methods:20 healthy New Zealand white rabbits were used to establish the rabbit VX2 hepatic tumor models by sigmoidectomy embedding method.18 experimental rabbits successfully planted were divided into two groups at random and were scanned by^ 31P-MRS about three weeks,and then respectively injected AdCMVIL12-IRES-CKb adenovirus and physiological saline into tumor and surrounding tissues by sigmoidectomy embedding method.^31P-MRS scan was again performed after animals were fed with creatine solution for five days.Meanwhile,IL-12 and CK were detected by immunohistochemistry(IHC) staining and agarose gel protein imprinting method(western blot).Results:After treatment of AdCMVIL12-IRES-CKb adenovirus,PCr peak in rabbits liver tumor tissues was obviously higher than that in control group,(0.84±0.41),(0.23±0.29) mmol/L respectively;pre-and post-treatment among the two groups,PCr peak is statistically significant(P〈0.05);the expressions of IL12 and CKB were detected in the liver in the experimental group by immunohistochemistry(IHC) staining and Western blot respectively,but not shown in the control group.Conclusion:It is feasibility to indirectly detect gene expression in liver by phosphorous-31 magnetic resonance spectroscopy(^31P-MRS) after virus directly gene transduction.
出处 《医学影像学杂志》 2011年第4期611-615,共5页 Journal of Medical Imaging
基金 国家自然科学基金资助项目(编号:30670591)
关键词 磷-31 磁共振波谱 肝癌 基因表达 31P Magnetic resonance spectroscopy Hepatic tumor Gene expression
  • 相关文献

参考文献14

  • 1Li Z,Qiao H,Lebhcrz C,et al.Creatine kinase,a Magnetic Resonance detectable marker gene for quantification of liverdirected gene transfer[J].Hum Gene Ther,2005,16:1429-1438.
  • 2柳曦,李欣,赵俊功,周承凯,冯敢生,戴文.兔VX_2肝癌模型制作及综合影像评价[J].实用放射学杂志,2002,18(2):132-134. 被引量:40
  • 3Gao Y,Strakowski SM,Reeves SJ,et ail.Fast spectroscopic imaging using online optimal sparsek space acquisition and projections onto convex sets reconstruction[J].Magn Reson Med,2006,55:1265-1271.
  • 4Lin FH.Sensitiity-encoded (SENSE) proton echo planar spectroscopic imaging (PEPSI) in the human brain[J].Magn reson Med,2007,57:249-257.
  • 5Kettunen MI,Grhn OH.Tumour gene therapy monitoring using magnetic resonance imaging and spectroscopy[J].Curr Gene Ther,2005,5:685-696.
  • 6Greenman RL.Quantification of the 31P metabolite concentration in human skeletal muscle from RARE image intensity[J].Magn Reson Med,2004,52:1036-1042.
  • 7Auricchio A,Zhou R,Wilson JM,et al.In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene[J].Proc Natl Acad Sci USA,2001,98:5205-5210.
  • 8刘强,李保朋,李子俊.磁共振波谱技术在肿瘤基因治疗效果评价中的应用价值[J].中华临床医师杂志(电子版),2009,3(3):58-61. 被引量:2
  • 9景猛,刘新权,梁鹏,李长宇,张相彤,王丹,栾钰,刘恩重.应用超顺磁性氧化铁纳米粒子标记神经干细胞及活体磁共振示踪的实验研究[J].中华医学杂志,2004,84(16):1386-1389. 被引量:31
  • 10Brosnan MJ,Chen L,Van Dyke TA,et al.Free ADP levels in transgenic mouse liver expressing creatine kinase,effects of enzyme activity,phosphagen type,and substrate concentration[J].J Biol Chem,1990,265:20849-20855.

二级参考文献34

  • 1曾蒙苏,张宏伟,周康荣,陆宏祺,严惠芳.供影像学诊断实验的大鼠移植肝癌模型的可行性研究[J].临床放射学杂志,1996,15(1):56-59. 被引量:14
  • 2Anderson W F, Blaese R M, Culver K, et al. The ADA human gene therapy clinical protocol: points to consider response with clinical protocol. Hum Gene Ther, 1990, 1:331-362.
  • 3Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al.Gene therapy of human severe combined immunodeficiency(SCID)-Ⅺ disease. Science, 2000, 288(5466): 669-672.
  • 4Pearson S, Jia H, Kandachi K. China approves first gene therapy. Nat Biotechnol, 2004, 22(1): 3-4.
  • 5Gura T. Hemophilia: after a setback, gene therapy progresses...gingerly. Science, 2001,291(5509): 1692-1697.
  • 6.[EB/OL].http://www.wiley.co.uk/genmed,.
  • 7Kohn D B, Sadelain M, Glorioso J C, et al. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat Rev Cancer, 2003, 3(7): 477-488.
  • 8Marshall E. Second child in French trial is found to have leukemia. Science, 2003, 299(5605): 320.
  • 9Ready T. Gene therapy in recovery phase. Nat Med, 2002,8(5): 429-430.
  • 10Sadelain M. Insertional oncogenesis in gene therapy: how much of a risk? Gene Ther, 2004, 11(7): 569-573.

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部